Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Bears control the stock market for now, but these takeover plays can keep the bulls satisfied
02:08pm, Saturday, 04'th Mar 2023 MarketWatch
S&P 500 has been under pressure since early February's false breakout, writes Lawrence McMillan.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - March 2023
09:30am, Saturday, 04'th Mar 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying, and are offering large discounts to their historical norms. We go ove
Should You Give Up on Novavax?
07:00pm, Friday, 03'rd Mar 2023 The Motley Fool
After a spectacular 2020 performance, Novavax's shares have plummeted.
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
02:00pm, Friday, 03'rd Mar 2023 Zacks Investment Research
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:33am, Friday, 03'rd Mar 2023
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Tracking George Soros's Portfolio - Q4 2022 Update
06:47am, Friday, 03'rd Mar 2023 Seeking Alpha
George Soros' 13F portfolio value increased from $5.86B to $7.26B this quarter. Click here to read the Q4 2022 Update on Soros Fund Management's portfolio.
Why Is Pfizer (PFE) Down 8.6% Since Last Earnings Report?
04:30pm, Thursday, 02'nd Mar 2023 Zacks Investment Research
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Pfizer Stock a Buy Now?
02:30pm, Thursday, 02'nd Mar 2023 The Motley Fool
Is this drug company just a "pandemic stock"?
Is Pfizer Stock a Buy Now?
09:30am, Thursday, 02'nd Mar 2023
Is this drug company just a "pandemic stock"?
GSK neck and neck with Pfizer in the race to get first RSV jab to market
05:19am, Thursday, 02'nd Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK)'s respiratory syncytial virus (RSV) vaccine has been endorsed by advisors to the US Food & Drug Administration, who assessed its safety and efficacy in older adults. The d
The 3 Best Recession Stocks to Buy for 2023
07:59pm, Wednesday, 01'st Mar 2023
Be it a slowdown or recession, portfolios need readjustment and relatively high exposure to some of the best recession stocks for 2023. In my opinion, the best recession stocks would typically be low-
Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'
06:21pm, Wednesday, 01'st Mar 2023 Benzinga
Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue.
Jim Cramer isn't surprised.
"I've been saying the
3 Value Stocks You'll Regret Not Buying on the Dip
01:45pm, Wednesday, 01'st Mar 2023 The Motley Fool
These three undervalued healthcare stocks are solid picks for patient investors.
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
06:01am, Wednesday, 01'st Mar 2023
Lucira Health Inc. (NASDAQ: LHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its combination at-home COVID-19 and a flu test
Pfizer takes lead in the race to be first with RSV jab
02:56am, Wednesday, 01'st Mar 2023
Pfizer Inc (NYSE:PFE)'s respiratory syncytial virus (RSV) vaccine has moved a step closer to being approved in the United States for older adults after a committee of outside advisers to the US health
